ClearRead +Detect™ (formerly OnGuard) is an advanced computer-aided detection (CAD) technology that identifies areas on a chest X-ray that may be early-stage lung cancer. The newest FDA approved version offers superior marking capabilities with an improved 75% reduction in false positives and improvement in sensitivity.